由于试验设计和比较器有缺陷,FDA拒绝了Moderna的mRNA流感疫苗,这引发了对监管一致性和创新的担忧. FDA rejected Moderna’s mRNA flu vaccine due to flawed trial design and comparator, raising concerns over regulatory consistency and innovation.

尽管Moderna声称符合监管机构的预期,并在其他国家获得了先前的批准,但FDA拒绝了该公司申请其mRNA流感疫苗,理由是对比器和试验设计不足. Despite Moderna's claims of meeting regulatory expectations and previous approvals in other countries, the FDA rejected the company's application for its mRNA flu vaccine, citing inadequate comparator and trial design. 自从Robert F. Kennedy Jr.被任命为HHS秘书以来,拒绝提交——通常为不完整的提交而采取的一项罕见行动——引起了关于监管一致性和可能的政治影响的问题。 Since Robert F. Kennedy Jr. was appointed HHS secretary, the refusal to file—a rare action usually reserved for incomplete submissions—has sparked questions about regulatory consistency and possible political influence. 产业执行官告诫说,这项裁决可能会阻碍为MRNA技术提供资金,从而妨碍创新,危及美国。 Industry executives caution that the ruling might discourage funding for mRNA technology, thereby impeding innovation and endangering the United States. 准备为公共卫生服务,特别是在严重流感季节。 readiness for public health, particularly during a severe flu season.